Global Antimicrobial Resistance Surveillance Market Size to Worth USD 9.92 Billion by 2032 | CAGR of 5.8%
Category: HealthcareGlobal Antimicrobial Resistance Surveillance Market Size to Worth USD 9.92 Billion by 2032
According to a research report published by Spherical Insights & Consulting, the Global Antimicrobial Resistance Surveillance Market Size is to grow from USD 5.61 Billion in 2022 to USD 9.92 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 5.8% during the projected period. Continued innovation in diagnostics, data integration, and international collaboration are expected to propel progress in this critical sector, ultimately protecting antibiotic efficacy and preserving global public health.
Get more details on this report -
Browse key industry insights spread across 200 pages with 100 market data tables and figures & charts from the report on The "Global Antimicrobial Resistance Surveillance Market Size, Share, and COVID-19 Impact Analysis, By Solution (Kits, System, Surveillance Software, Service), By Application (Clinical Diagnostics, Public Health Surveillance), By End User (Hospitals, Clinics, Academic, Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/antimicrobial-resistance-surveillance-market
Antimicrobial resistance (AMR) is one of today's most pressing public health issues, and the global antimicrobial resistance surveillance market is critical to addressing it. When microorganisms, such as bacteria and viruses, develop resistance to the medications designed to treat them, the medications become less effective or ineffective. The urgent need for robust surveillance systems that can monitor and track the spread of AMR is driving this burgeoning market, allowing healthcare professionals to make informed decisions about antibiotic prescriptions and treatment strategies. Advanced laboratory techniques, data analytics, and information sharing platforms that enable the collection and analysis of data from healthcare facilities, laboratories, and clinics around the world are key components of the global antimicrobial resistance surveillance market. This data-driven approach enables healthcare stakeholders to detect emerging resistance patterns, create targeted interventions, and create new antimicrobial therapies. The lack of standardized AMR surveillance methods and guidelines can impede data comparability and interoperability across regions and countries. Because of this lack of standardization, establishing a cohesive global surveillance network is difficult.
The kits segment accounted for a significant share of the global antimicrobial resistance surveillance market in 2022.
The global antimicrobial resistance surveillance market is divided into kit, system, surveillance software, and service segments. In 2022, the kits segment accounted for a sizable portion of the global antimicrobial resistance surveillance market. Diagnostic reagents and consumables used in laboratories to detect and identify antimicrobial-resistant pathogens are included in AMR surveillance kits. These kits are required for performing microbiological tests in order to determine the resistance profiles of infectious agents. Culture media, antibiotic susceptibility testing (AST) panels, and molecular testing reagents are common examples.
The clinical diagnostics segment is expected to hold the largest share of the global antimicrobial resistance surveillance market during the forecast period.
The global antimicrobial resistance surveillance market is classified into clinical diagnostics and public health surveillance. The clinical diagnostics segment is expected to account for the majority of the global antimicrobial resistance surveillance market during the forecast period. Clinical diagnostics primarily focus on identifying antimicrobial resistance in individual patients in healthcare settings such as hospitals and clinics. The goal is to help healthcare providers choose the most effective antibiotic treatments for infected patients. This category includes diagnostic tests and tools that are directly used in patient care.
North America is anticipated to hold the largest share of the global antimicrobial resistance surveillance market over the predicted timeframe.
Get more details on this report -
North America has well-established healthcare systems and cutting-edge laboratory facilities, including the United States and Canada. These countries invest heavily in AMR surveillance, with a particular emphasis on clinical diagnostics and data collection. Because of the region's robust healthcare infrastructure and high patient care standards, clinical diagnostics have held a significant share in North America. In the United States, the CDC (Centers for Disease Control and Prevention) is in charge of AMR surveillance.
During the forecast period, Asia Pacific is projected to expand at the fastest rate in the global antimicrobial resistance surveillance market. China has made significant investments in AMR surveillance, including the establishment of a national data collection network. In addition, the Asia-Pacific region works with international organizations such as the World Health Organization (WHO). Because of its diverse healthcare systems and population sizes, the Asia-Pacific region, which includes China and India, faces unique challenges. The Asia-Pacific region is seeing an increase in public health surveillance, due to regional and global health organizations and initiatives.
Major vendors in the Global Antimicrobial Resistance Surveillance Market include Luminex Corporation, Thermo Fisher Scientific, BioSpace, Cepheid, Accelerate Diagnostics, Inc., Liofilchem S.r.l., Becton, Dickinson and Company, Biomerieux, Bruker, Danaher, Merck KgaA, Bio-Rad, Qiagen, Abbott Laboratories, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the Global Antimicrobial Resistance Surveillance Market based on the below-mentioned segments:
Global Antimicrobial Resistance Surveillance Market, By Solution
- Kits
- System
- Surveillance Software
- Service
Global Antimicrobial Resistance Surveillance Market, By Application
- Clinical Diagnostics
- Public Health Surveillance
Global Antimicrobial Resistance Surveillance Market, By End User
- Hospitals
- Clinics
- Academic
- Research Institutes
Global Antimicrobial Resistance Surveillance Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?